Skip to main content

Advertisement

Open Peer Review Reports for: Response to Imatinib therapy is inferior for e13a2 BCR-ABL1 transcript type in comparison to e14a2 transcript type in chronic myeloid leukaemia

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
26 Sep 2018 Submitted Original manuscript
3 Nov 2018 Reviewed Reviewer Report - Susan - Branford
7 Jan 2019 Reviewed Reviewer Report - Reviewer 2
22 Feb 2019 Author responded Author comments - Graeme Greenfield
Resubmission - Version 2
22 Feb 2019 Submitted Manuscript version 2
5 Mar 2019 Reviewed Reviewer Report - Susan - Branford
22 Mar 2019 Author responded Author comments - Graeme Greenfield
Resubmission - Version 3
22 Mar 2019 Submitted Manuscript version 3
Publishing
8 Apr 2019 Editorially accepted
2 May 2019 Article published 10.1186/s12878-019-0139-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement